Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.05%
SPX
+0.51%
IXIC
+1.02%
FTSE
+0.67%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest KalVista Pharmaceuticals News

benzinga.com

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com
13 days ago
benzinga.com

FDA Approves KalVista's Ekterly As First Oral On-Demand Treatment For Rare Swelling Disease

Feature Image for interests on Biotech, Briefs, Healthcare, News from benzinga.com
about 2 months ago
businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock from businesswire.com
7 months ago
businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock from businesswire.com
8 months ago
businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock from businesswire.com
8 months ago
businesswire.com

KalVista Appoints Jeb Ledell as Chief Operating Officer

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
businesswire.com

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
businesswire.com

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
businesswire.com

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Healthcare, Stock from businesswire.com
9 months ago
Stocks
Health Care
kalv
KalVista Pharmaceuticals
NASDAQ: KALV
-0.13 (-0.94%)
14.155
USD
At close at Sep 03, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

KalVista Pharmaceuticals and Ionis Lead Innovation in Hereditary Angioedema Treatment with FDA Approval

10 days ago
publisher logo
Cashu

KalVista Pharmaceuticals Observes Ionis FDA Approval for Innovative HAE Treatment IONS Dawnzera

12 days ago
publisher logo
Cashu

KalVista Pharmaceuticals and the Growing Landscape of HAE Treatments Following Ionis Approval

14 days ago